FormFactor, Inc. (FORM): what the price requires

At today's price, FormFactor, Inc. (FORM) is priced for today's economics sustained for ~29.0 years. boothcheck doesn't publish a fair value or a price target; it shows what the price assumes, so you can judge whether that bar is too high.

Generated: 2026-07-19 · Source: https://boothcheck.com/report/FORM

Headline

FieldValue
TickerFORM
CompanyFormFactor, Inc.
Current price$110.95/sh

What The Price Requires (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basiswhole-company
Operating margin today6.3%
Must persist for29.0y
Multiple paid149x operating income

Solve inputs: computed at a 12.9% cost of capital; growth searched up to the 25% self-funding ceiling; each 1pp moves the implied horizon ~3.6 years.

Reconcile: at the x-ray's 9.3% required return this reads ~17.9 years; the models below use their own rates.

How unusual the bet is: elevated

ReferenceValue
vs own history+0.47σ
sustained it ~10 years at this level15%
implied end-window share0%

Valuation X-Ray

Every valuation family lands below the price. The price therefore requires assumptions beyond what those standard frames encode.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset13.22x4expensive
Earnings10.89x4expensive
Relative3.40x5expensive
Growth1.57x3expensive

Families that call it expensive: Asset, Earnings, Relative, Growth

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 9.2%); the inversion above states its own rate.

Per-Model Detail (n=16)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowth$11.899.33xyesFCF base $0.0B, growth 11% (input: historical growth), terminal g 4.0%, WACC 9.2%, 6yr projection
DCF Exit MultipleGrowth$93.791.18xyesExit EV/EBITDA: 107.5x / 109.5x / 111.5x (bear / base = today's held flat / bull), 6yr
Relative ValuationRelative$41.222.69xyesP/E 48.4x (blended: static sector reference 22x + trailing (TTM) 129x), scenarios: 40.0x / 48.4x / 56.8x (bear / base = reference held flat / bull), EV/EBITDA 35.2x
Simple DDMGrowth——no—
Two-Stage DDMGrowth——no—
Simple Excess ReturnAsset$9.3011.93xyesBV/sh $13.33, ROE (TTM) 6.5%, ke 9.3%
Two-Stage Excess ReturnAsset$7.6514.50xyes5yr excess ROE then converge to ke=9.3%
Discounted Future Market CapGrowth$70.891.57xyesRev $0.8B, growth 11% (input: historical growth; tapered), Terminal P/S: 6.6x / 8.0x / 9.4x (bear / base = today's held flat / bull, cap 8x)
Peter Lynch Fair ValueRelative$30.453.64xyesEPS $0.87, growth 35% (input: historical EPS growth), PEG=3.68 (Overvalued)
Margin TrajectoryGrowth——no—
Earnings Power ValueEarnings$11.119.99xyesNormalized EBIT (5y avg op income, one-time charges added back) $0.08B × (1−2%) / WACC 9.2% → EPV (no growth)
Residual IncomeAsset$7.4214.95xyesBV $13.33 + 5yr PV of (ROE (TTM) 6.5% − Kₑ 9.3%) × BV; BV grows 4.2%/yr
Graham NumberAsset$16.156.87xyes√(22.5 × EPS $0.87 × BVPS $13.33) — Graham's conservative floor
EV/EBITDA RelativeRelative$17.206.45xyesEBITDA $0.08B × sector EV/EBITDA 16.0x
FCF YieldEarnings$6.1318.10xyesFCF $36.6M / Kₑ 9.3% — zero-growth perpetuity
SBC-Adj FCF YieldEarnings——no—
Ben Graham FormulaEarnings$28.073.95xyesEPS $0.87 × (8.5 + 2×15.0%) × (4.4 / 5.3%)
ROIC-Justified P/BAsset$2.4345.66xyesBV $13.33 × (ROIC 1.7% / WACC 9.2%) (excluded from median)
P/Sales SectorRelative$52.872.10xyesRevenue $0.84B × sector P/S 5.0x
PEG Fair ValueRelative$32.633.40xyesEPS $0.87 × (PEG 1.5 × growth 25.0% (input: historical EPS growth)) → PE 37.5x
Earnings YieldEarnings$9.4111.79xyesEPS $0.87 / required return 9.3% (Rf 4.3% + ERP 5.0%)
Funds From Operations MultipleRelative——no—
Clinical Phase NPVGrowth——no—
MertonAsset——no—
V5 Mechanical———no—

Solvency

FieldValue
Net cash$291.1m
Net debt / NOPAT (after-tax)-5.92x (net cash)
Net debt / operating income (pre-tax)-5.80x (net cash)
Share count CAGR (dilution)0.0%
Burning cashno

Interest expense is not separately reported in the latest filings, so interest coverage cannot be computed.

Bullet Takeaways

FormFactor's moat is its position as the largest probe-card maker in the world, the company memory and logic chipmakers rely on to test wafers before shipment. The product is custom-engineered to each customer's chip layout, which makes it sticky, and that stickiness is the source of the franchise.

The price near $149.45 is rich on any trailing measure, working out to a very high multiple of operating income because margins are coming off a cyclical low. The inversion reads it as elevated, implying many years of sustained fast growth, far more than most companies deliver.

The offsetting fact is a sharp earnings inflection underway. The latest quarter posted record revenue up about 32% and a gross margin near 49% as high-bandwidth memory testing surged for AI chips. The bet is that the HBM cycle keeps lifting earnings into the multiple; the risk is paying a peak valuation on a cyclical semiconductor supplier.

Bull Case

FormFactor's competitive advantage is structural and shows up in the returns when the cycle cooperates: it is the world's largest manufacturer of probe cards, the specialized fixtures that test semiconductor wafers before the chips are packaged and shipped. The moat is the customization. The filing describes proprietary "probe card design tools and processes" built "to enable the rapid and accurate customization of products required to meet customer requirements," adapting "standard product architectures to meet each customer's specific wafer layouts, chip layouts" [FY2025 10-K, accession 0001039399-26-000009]. A probe card designed into a customer's test flow is hard to displace mid-program, which gives FormFactor pricing power and recurring design wins as chip designs evolve.

The demand inflection is the heart of the current bull case, and it is tied to the most important trend in semiconductors. AI accelerators need high-bandwidth memory, and HBM is complex, high-value, and must be tested rigorously, which plays directly to FormFactor's strength. In the first quarter of 2026 the company posted record revenue of $226.1 million, up about 32% year over year, with non-GAAP gross margin jumping to 49%, well above its own target, and non-GAAP earnings of $0.56 a share, up about 143%. Record DRAM revenue of $82.9 million rose nearly 70% on HBM demand, and probe-card revenue of $198.2 million grew about 45%. The company guided second-quarter revenue to about $240 million and pointed to record DRAM probe-card revenue ahead as HBM demand steps up again, including a second customer adopting its differentiated full-wafer contactor technology.

The balance sheet and market position let it press the advantage. FormFactor carries net cash of roughly $291 million and no funding pressure, so it can invest in next-generation probe architectures ahead of customer adoption, exactly the kind of forward spending the filing describes incurring "in advance of customer adoption" of new semiconductor technologies [FY2025 10-K, accession 0001039399-26-000009]. As a key supplier to the top HBM makers heading into the HBM4 generation, FormFactor is positioned to ride the AI-memory ramp with the leading product, a strong balance sheet, and operating leverage that turns revenue growth into outsized earnings growth.

Bear Case

FormFactor's balance sheet is strong, with net cash and no leverage, so the fragility is not financial; it is the operating-leverage and cyclicality profile that sits beneath a very high valuation. The same operating leverage that makes earnings soar when demand is strong makes them collapse when it is weak. Probe-card demand is a function of semiconductor capital spending and new chip introductions, both of which are famously cyclical. FormFactor spends ahead of the cycle, the filing noting that expenses for new architectures "are often incurred in advance of customer adoption" [FY2025 10-K, accession 0001039399-26-000009], so in a downturn costs stay while revenue falls, and margins compress fast. The trailing earnings the valuation is measured against reflect how thin margins can get; the recent surge is the up-leg of that same lever, and up-legs do not last forever in semiconductors.

Customer concentration sharpens the cyclicality into single-point risk. FormFactor sells to a small number of large chipmakers, and the filing discloses that one customer represented a double-digit share of revenue, anticipating that "sales of our products to a relatively small number of customer" will continue to dominate [FY2025 10-K, accession 0001039399-26-000009]. The HBM boom is concentrated among a handful of memory makers, so the same names driving the upside are the ones whose order pauses would drive the downside. A single large customer adjusting its HBM capacity plans, or a digestion phase in AI-memory buildout, would hit FormFactor disproportionately.

The valuation leaves no room for any of that. At about $149.45 (June 27, 2026) no valuation family reaches the price: on trailing numbers the multiple of operating income is extraordinarily high, and the inversion implies the company must sustain fast growth for decades, a pace only a small fraction of companies achieve. Even on the inflected, post-HBM run-rate, the price embeds a P/E that analysts have flagged as rich, with the consensus price target sitting below the current price. The conservative methods anchor near a book value of $13.33 and a normalized earnings power far below the price. The bear case is straightforward: this is a cyclical semiconductor supplier priced for a permanent boom, and if the HBM cycle cools or a key customer pauses, the gap between the price and every fundamental anchor would close downward.

Valuation

FormFactor is valued as a whole company off its operating income, and on the trailing numbers the read is extreme. At about $149.45 the price works out to roughly 202 times company-wide operating profit, because margins were coming off a cyclical low, which inverts to an assumption that the company sustains growth near its self-funding ceiling for about thirty-four years. That is a single solve under a 13.3% cost of capital, so it is approximate and the reliability is flagged as low, but the direction is unambiguous: the priced-in assumption is elevated, far beyond what most companies deliver, with only about 15% of comparable fast-growers sustaining such a pace for even a decade.

The X-ray confirms that no valuation family reaches the price. The asset-based methods anchor near a book value of $13.33 with a trailing return on equity of 6.5%, landing in the high single digits, the earnings-power frame lands near $11 on depressed normalized operating income, and even the relative and forward-growth frames sit well below the price. The one frame that approaches it, the DCF-exit-multiple, requires an enormous exit multiple to get there. The characterization is direct: the price is rich on assets, earnings power, peers, and even forward growth, a bet beyond what any standard frame supports.

The fair reconciliation is that the trailing methods are measuring a trough that the business has already begun to exit. The recent quarter's revenue surge and 49% gross margin show earnings inflecting hard on the HBM cycle, so the forward earnings base is meaningfully higher than the trailing one the inversion uses. But even crediting the inflection, the valuation is demanding: on the higher run-rate the multiple is still rich, and analysts' price targets sit below the current price. The honest read is that this is a high-quality cyclical priced for the up-cycle to be both large and durable, with the burden of proof on the HBM ramp continuing through HBM4 and beyond.

Catalysts

The most recent catalyst was the first-quarter 2026 report, which was a record. FormFactor delivered revenue of $226.1 million, up about 32% year over year, non-GAAP gross margin of 49% well above its target, and non-GAAP earnings of $0.56 a share, up about 143% and ahead of estimates. Record DRAM revenue of $82.9 million rose nearly 70% on HBM demand, and the company guided second-quarter revenue to about $240 million with non-GAAP earnings around $0.61. Each quarterly print is the key gauge of whether the HBM-driven inflection is sustaining.

The dominant forward catalyst is the high-bandwidth-memory ramp for AI. FormFactor pointed to record DRAM probe-card revenue ahead, driven by another step-up in HBM demand and a second customer adopting its full-wafer contactor technology, and the industry transition to HBM4 mass production is the multi-quarter tailwind. New design wins in foundry and logic, including probe cards for networking applications, broaden the growth beyond memory.

The swing factors are the cycle and concentration. Semiconductor capital spending and the pace of AI-memory buildout drive probe-card demand, so any digestion phase or capacity-plan change at a major HBM maker is the key risk, amplified by FormFactor's customer concentration. Valuation is itself a catalyst risk: the stock trades at a rich multiple, the analyst consensus rating is positive but the average price target sits below the current price, and the stock has been volatile around earnings, so any growth disappointment against the high expectations embedded in the price could be punished. The watch items are HBM order trends, gross-margin direction, and customer concentration.

Sources: FormFactor Q1 2026 record revenue and margins, StockTitan; FORM Q1 earnings beat, revenues rise, Yahoo Finance; AI and HBM demand lift FormFactor Q1 2026, StockTitan; FormFactor HBM4 earnings inflection, Seeking Alpha; FormFactor analyst ratings and targets, Benzinga.

Peer Cohorts (Per Segment, With Filing Citations)

Core business (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

View the full interactive FORM report on boothcheck